Literature DB >> 16625047

Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.

Juliana Sekeres Mussalem1, José Ronnie C Vasconcelos, Carla Cristina Squaiella, Renata Zeigler Ananias, Eleni Gonçalves Braga, Maurício M Rodrigues, Ieda Maria Longo-Maugéri.   

Abstract

In the present work we investigated the role of killed Propionibacterium acnes or a soluble polysaccharide extracted from bacterium cell wall in modulated experimental immunization with plasmidial DNA. We used a plasmid, p154/13, containing a gene-encoding catalytic domain of Trypanosoma cruzi (T. cruzi) trans-sialidase. As previously described, immunization of BALB/c mice with p154/13 elicited humoral, cell-mediated and protective immune responses against T. cruzi infection. In this study we describe that both P. acnes and its soluble polysaccharide fraction have the ability to modulate the immune response elicited by p154/13. Treatment with these adjuvants enhanced specific trans-sialidase Th1 immune response, as revealed by a lower IgG1/IgG2a ratio and stronger in vitro IFN-gamma synthesis by CD4+ T cells. The most important fact was that treatment with P. acnes or its soluble polysaccharide fraction in the presence of p154/13 significantly reduced the peak of parasitemia observed 7 to 8 days after T. cruzi challenge. These data suggest that P. acnes or its soluble polysaccharide fraction may improve the protective potential of a DNA vaccine against experimental T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625047     DOI: 10.1111/j.1348-0421.2006.tb03791.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  17 in total

1.  beta-Glucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen.

Authors:  Jing Wang; Shengfu Dong; Chunhong Liu; Wei Wang; Shuhui Sun; Jianxin Gu; Yuan Wang; Diana Boraschi; Di Qu
Journal:  J Biomed Biotechnol       Date:  2010-06-10

2.  Specific humoral immune response induced by propionibacterium acnes can prevent Actinobacillus pleuropneumoniae infection in mice.

Authors:  Feng Yang; Qiuyue Ma; Liancheng Lei; Jing Huang; Qun Ji; Ruidong Zhai; Lei Wang; Yu Wang; Linxi Li; Changjiang Sun; Xin Feng; Wenyu Han
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

3.  Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

Authors:  Teruaki Nakatsuji; Yu-Tsueng Liu; Cheng-Po Huang; Christos C Zoubouis; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

4.  Adjuvant effect of killed Propionibacterium acnes on mouse peritoneal B-1 lymphocytes and their early phagocyte differentiation.

Authors:  Juliana Sekeres Mussalem; Carla Cristina Squaiella-Baptistão; Daniela Teixeira; Tatiana Mina Yendo; Felipe Garutti Thies; Ana Flavia Popi; Mario Mariano; Ieda Longo-Maugéri
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

5.  Modulation of Th1/Th2 immune responses by killed Propionibacterium acnes and its soluble polysaccharide fraction in a type I hypersensitivity murine model: induction of different activation status of antigen-presenting cells.

Authors:  Carla Cristina Squaiella-Baptistão; Daniela Teixeira; Juliana Sekeres Mussalem; Mayari Eika Ishimura; Ieda Maria Longo-Maugéri
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

Review 6.  Prophylactic and therapeutic DNA vaccines against Chagas disease.

Authors:  Minerva Arce-Fonseca; Martha Rios-Castro; Silvia del Carmen Carrillo-Sánchez; Mariana Martínez-Cruz; Olivia Rodríguez-Morales
Journal:  Parasit Vectors       Date:  2015-02-24       Impact factor: 3.876

7.  The adjuvant effects of high-molecule-weight polysaccharides purified from Antrodia cinnamomea on dendritic cell function and DNA vaccines.

Authors:  Chi-Chen Lin; I-Hong Pan; Yi-Rong Li; Yi-Gen Pan; Ming-Kuem Lin; Yi-Huang Lu; Hsin-Chieh Wu; Ching-Liang Chu
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

8.  Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses.

Authors:  Carolina S Paladi; Danielle A M da Silva; Priscila D Motta; Daniel M Garcia; Daniela Teixeira; Ieda M Longo-Maugéri; Simone Katz; Clara L Barbiéri
Journal:  Front Microbiol       Date:  2017-03-06       Impact factor: 5.640

9.  Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis.

Authors:  Josie Haydée Lima Ferreira; Lucilene Dos Santos Silva; Ieda Maria Longo-Maugéri; Simone Katz; Clara Lúcia Barbiéri
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

Review 10.  An Overview of B-1 Cells as Antigen-Presenting Cells.

Authors:  Ana F Popi; Ieda M Longo-Maugéri; Mario Mariano
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.